Welcome edit

Hello, Ocyan, and welcome to Wikipedia. Thank you for your contributions. I hope you like the place and decide to stay. If you are stuck, and looking for help, please come to the New contributors' help page, where experienced Wikipedians can answer any queries you have! Or, you can just type {{helpme}} and your question on this page, and someone will show up shortly to answer. Here are a few good links for newcomers:

We hope you enjoy editing here and being a Wikipedian! By the way, you can sign your name on talk and vote pages using four tildes, like this: ~~~~. If you have any questions, see the help pages, add a question to the village pump or ask me on my talk page. Again, welcome! Active Banana ( bananaphone 18:00, 24 August 2010 (UTC)Reply

Sipuleucel-T‎ edit

You have 5 minutes to explain your edit before I fully protect the page. Shubinator (talk) 04:32, 25 August 2010 (UTC)Reply

Shubinator, I guess you meant I should write here.

What I have done was to summarize the trial results from all three phase-3 trials for Sipuleucel-T in the simplest form that I could think of. I've referenced every data point as well as every discussion point with existing publications from the Journal of Clincical Oncology, New England Journal of Medicine and others from the FDA as appropriate.

Since all facts and discussions were taken from published sources, the summarized information should be as objective as possible. I believe that the presented information is important for readers who wish to know why Sipuleucel-T is an efficacious treatment.

If you see any errors, please point them out. Thank you. Ocyan (talk) 04:55, 25 August 2010 (UTC)Reply

My bad, I meant that I was in the process of posting to Talk:Sipuleucel-T, so please post there instead. Thank you for discussing before editing. Shubinator (talk) 05:00, 25 August 2010 (UTC)Reply
I'm heading to bed. We'll continue this tomorrow. Be aware that you and SaulK are close to being indefinitely blocked. I do appreciate your willingness to discuss the issue. However, other admins might see the situation differently and pull the trigger. I'm giving you a chance. Shubinator (talk) 05:28, 25 August 2010 (UTC)Reply


Shubinator -

This is my first time posting on Wikipedia. You keep saying that I have some sort of agenda while all I am doing is to take my best effort to communicate some scientific information in a way as accurate as possible and as simple as possible. This is in the same spirit that I have seen from reading other Wikipedia pages with far more technical details about a variety of topics in different fields of science.

I am a scientist so what I write is always in the spirit that they must be as complete as possible and verifiable by others. In fact, I see much missing as well as misleading information on the current page. For example, if you talk to any practicing oncologist, they will tell you that if a survival benefit is seen, then the disease must have been stopped or slowed down in some way. Thus, the lack of evidence for progression must be examined carefully. And, that's what the discussion on Time to progression on my version of the page was about. In fact, your portrayal of the lack of evidence for "actually affecting the progression of cancer" and the conjecture of Dr. Longo was one-sided when, in fact, there is evidence for affecting progression as seen in the D9901 trial of Sipuleucel-T.

It is important that a public source of information such as Wikipedia should be as accurate and complete as we can help make it. Even if as an administrator you could simply ban me as you mentioned, you should at least read what I wrote carefully to incorporate the "factual information" there so that people who come to Wikipedia to seek information would not be misled.

Truly, I have no agenda but to see the facts about Sipuleucel-T be presented right.

Thanks for listening.

Ocyan (talk) 06:02, 25 August 2010 (UTC)Reply

Ocyan please respond edit

O--I tried the email address you gave me but it came back with a failure notice. Could you please email me at saul_kerpelman@yahoo.com? Thanks —Preceding unsigned comment added by SaulK (talkcontribs) 12:34, 10 September 2010 (UTC)Reply